Table 3.
Characteristic | CSF WBC, Median (IQR) | CSF RBC, Median (IQR) | CSF Protein, Median (IQR) | CSF Glucose, Median (IQR) | |
---|---|---|---|---|---|
CSF characteristics | |||||
HSE cases (n = 60) | 50 (22–76) | 48 (12–77) | 75 (48–105) | 65 (54–74) | |
All non-HSE cases (n = 191) | 32 (2–65)a | 33 (2–60)a | 57 (41–96)a | 65 (54–82) | |
Other non-HSE infectious cases (n = 48) | 32 (7–79) | 38 (12–66) | 66 (47–158) | 61 (43–68) | |
Autoimmune cases (n = 21) | 38 (22–79) | 27 (1–74) | 54 (33–118) | 61 (49–73) | |
Characteristic | Bilateral Temporal Lobe, No. (%) | Lesions Outside of Temporal Lobe, Cingulate, or Insula, No. (%) | Restricted Diffusion, No. (%) | Hemorrhage, No. (%) | Enhancement, No. (%) |
MRI characteristics | |||||
HSE cases (n = 60) | 12/56 (21) | 17/56 (30) | 16/56 (29) | 5/56 (9) | 22/56 (39) |
All non-HSE cases (n = 191) | 70/153b (46) | 89/158b (56) | 34/158 (22) | 10/157 (6) | 64/159 (40) |
Other non-HSE infectious cases (n = 48) | 19/39c (49) | 22/39c (56) | 13/39 (33) | 0/39c (0) | 19/41 (46) |
Autoimmune cases (n = 21) | 10/19d (53) | 12/20d (60) | 5/20 (25) | 2/20 (10) | 10/20 (50) |
Boldface indicates a statistically significant difference in characteristic between HSE and other etiologies.
Abbreviations: CSF, cerebrospinal fluid; HSE, herpes simplex encephalitis; IQR, interquartile range; MRI, magnetic resonance imaging; RBC, red blood cell; TL, temporal lobe; WBC, white blood cell.
a HSE compared with non-HSE cases: CSF WBC count, P = .003; CSF RBC count, P = .020; CSF protein, P = .043.
b HSE compared with non-HSE cases: bilateral TL involvement, P = .001; lesions outside of TL, cingulate, or insula, P = .001.
c HSE compared with other infectious cases: bilateral TL involvement, P = .005; lesions outside of TL, cingulate, or insula, P = .011; presence of hemorrhage, P = .055.
d HSE compared with autoimmune cases: bilateral TL involvement, P = .010; lesions outside of TL, cingulate, or insula, P = .019.